All In Biotech

Drug Trial Radar · NCT05321316

Nectin-4 Specific LMW PET Probe Imaging in Multiple Solid Tumors

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

May 31, 2025

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Peking University Cancer Hospital & InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 11, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the ability of \[68Ga\]NT-CBH to detect nectin-4 overexpression in subjects with urinary system cancers, breast cancer, lung cancer, pancreatic cancer, gastrointestinal cancer, and ovarian cancer.

Conditions

  • Urothelial Carcinoma
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Gastrointestinal Cancers
  • Ovarian Cancer

Interventions

  • 18F-FDGDrug

    All study participants will undergo one 18F-FDG PET/CT scan.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Standardized uptake value(SUV)Time frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beijing Cancer Hospital

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.